Status:
COMPLETED
Effectiveness of Epidermal Growth Factor-containing Ointment on the Solar Lentigines
Lead Sponsor:
Hallym University Kangnam Sacred Heart Hospital
Conditions:
Epidermal Growth Factor
Nd-yttrium Aluminum Garnet Laser
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Subjects were randomly assigned to groups for treatment with either an EGF-containing ointment (the study group) or the vehicle alone (petrolatum; the control group). The EGF ointment included recombi...
Eligibility Criteria
Inclusion
- Clinical diagnosis of solar lentigines that occurred after adulthood
- age of 20 years or older.
Exclusion
- uncontrolled systemic or chronic disease
- hypersensitivity to the ingredients of the ointment
- current use of skin whitening agents
- a history of other laser treatments within the past 6 months
- pregnancy
- lactation.
Key Trial Info
Start Date :
July 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 26 2018
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04704245
Start Date
July 20 2017
End Date
December 26 2018
Last Update
January 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kangnam Sacred Heart Hospital
Seoul, South Korea